about
Chronic intermittent psychological stress promotes macrophage reverse cholesterol transport by impairing bile acid absorption in mice.Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.Sitosterolemia: diagnosis, investigation, and management.Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.HDL and lifestyle interventions.Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.LXR-dependent regulation of macrophage-specific reverse cholesterol transport is impaired in a model of genetic diabesity.Quantification of In Vitro Macrophage Cholesterol Efflux and In Vivo Macrophage-Specific Reverse Cholesterol Transport.Hypoxia worsens the impact of intracellular triglyceride accumulation promoted by electronegative low-density lipoprotein in cardiomyocytes by impairing perilipin 5 upregulation.PPAR-β/δ activation promotes phospholipid transfer protein expression.Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.Hormonal regulation of lipoprotein lipase activity from 5-day-old rat hepatocytes.Proteomic analysis of electronegative low-density lipoproteinHepatic regeneration induces changes in lipoprotein lipase activity in several tissues and its re-expression in the liver.Anomalous lipoproteins in obese Zucker rats.Lipoprotein lipase and cholesterol transfer activities of lean and obese Zucker rats.Ultracentrifugation micromethod for preparation of small experimental animal lipoproteins.Mechanisms of HDL deficiency in mice overexpressing human apoA-II.Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties.Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion.Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer.Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism.Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.Propolis nasal spray effectively improves recovery from infectious acute rhinitis and common cold symptoms in children: a pilot study.A novel homozygous mutation causing lecithin-cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemia.Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake.Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery.ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways.Effect of fasting on hepatic lipase activity in the liver of developing rats.Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic miceAutosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical settingDifferential intestinal mucosal protein expression in hypercholesterolemic mice fed a phytosterol-enriched dietSeeking Novel Targets for Improving In Vivo Macrophage-Specific Reverse Cholesterol Transport: Translating Basic Science into New Therapies for the Prevention and Treatment of Atherosclerosis
P50
Q30409183-A4F7801E-B3F4-49FD-A753-6346C21B0C94Q30884071-A853C81A-941E-4555-B7F2-9A48FED2C63EQ33415263-50005A52-068B-421C-948B-E6965D785533Q34065528-C6CFD75A-FA8E-4A1A-BB44-2A7455AEBD60Q35014223-6198401B-48A4-4BDB-AB1C-B19E5E2DFDEFQ36744086-219ECEB7-5482-4B6C-A99B-5EACF5F4D1CCQ38293496-A189BF20-3C52-488E-87DD-F625D07CA9CDQ38730033-8DFFC9F2-752D-40B9-B85F-82E1D423F738Q38742329-B72A1DB6-9682-4E7A-BDEF-6479FCA5CA23Q38829669-CAE3C019-B364-4EB5-851C-A4E5D9A972FBQ38861588-DCA95FD0-DB35-467F-8CFD-E5384634C8DFQ38911717-2621BA23-7C8C-4557-A138-556727144BBFQ39141274-AE890EB4-ED81-46BC-BBCB-27639E535D63Q39245815-5FF7A24F-C0BB-4789-A7A0-099D0A94231CQ39624659-4B6A2510-049C-4DA3-BC59-8F7EB3BB7647Q41238721-4D4CF7B2-A9F0-4C8D-9AF2-B808B4D11B0FQ42377200-DAD65BCF-EC0B-4C14-82F0-A8E5A57A1A65Q42983627-6B15C289-8B88-452C-8AAB-FA7C835753E2Q43718277-225D580B-7291-48DD-9945-6B997CBEF2E2Q43729301-8476F71D-43C3-490C-9DB2-AF0F8957AA5FQ43924827-3CBDF614-D925-4E39-9332-0F28FD416EA7Q44168323-FADB8588-3DBB-4082-B326-B451B7CEA97EQ44183626-10733942-7FBB-406C-B3D2-0DB92EDBE370Q44536729-E48858A1-BF70-4101-BEE6-D37E9BC7C814Q45075496-7D0D489D-3413-4B0F-9D93-635AC2A44C33Q45771241-EEE616E1-6C18-4264-90CE-6E0885D5CE7BQ45858580-7F4D3A2F-3B2E-47F2-9D16-3310470E8C08Q46754440-CA9C3F0A-A65F-4D6B-8565-365F7928DA70Q46962860-16532D3F-DD74-4E0D-B205-C6DA70E3AEAFQ47103066-A6C59243-8E07-4033-98A2-AD66552E75EEQ49650532-C1790DAD-B4C6-41FA-9D7D-4CFF0480C454Q49891108-643C9305-2E2A-4980-804B-010F9391C3FDQ50482800-9E6A60AC-0EB5-4D7D-9CCB-6C1DBC404A3CQ50616462-571909FD-3EAC-4041-8732-55BAC1AE776AQ51369260-356E7D52-CC6C-4A80-B894-B852701E836DQ51558508-6A072338-926E-4805-8B71-479B1871F1C9Q57031178-1001F78E-C3EA-4B74-BFE4-8B1A68FD5565Q57192292-AA454852-FBBA-4647-820D-932C71BCC331Q57353762-48789E59-BC04-4890-8DAD-AE1FCD73AF5FQ61767150-FA083308-C42B-489B-B6FC-B02D5BED139C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Josep Julve
@ast
Josep Julve
@en
Josep Julve
@es
Josep Julve
@nl
type
label
Josep Julve
@ast
Josep Julve
@en
Josep Julve
@es
Josep Julve
@nl
prefLabel
Josep Julve
@ast
Josep Julve
@en
Josep Julve
@es
Josep Julve
@nl
P106
P1153
6603732637
P21
P31
P496
0000-0002-6531-2246